{"url_path":"/sec/nvax/8-k/2026-01-12/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-01-12","source_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001104659-26-002725-index.html","accession_number":"0001104659-26-002725","cik":"0001000694","ticker":"NVAX","issuer_name":"NOVAVAX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1000694/0001104659-26-002725-index.html","primary_entity_key":"0001000694","primary_entity_name":"NOVAVAX INC"},"word_count":263,"has_tables":true,"body_markdown":"**Item 7.01.**\n**Regulation FD Disclosure.**\n\n \n\nOn January 12, 2026, the Company plans to\nprovide an update for investors at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, presenting information\nrelating to certain strategic and business updates (the “Investor Presentation”), which is attached as Exhibit 99.1 to\nthis Current Report on Form 8-K and incorporated into this Item 7.01 by reference. A copy of the Investor Presentation will also\nbe accessible on the Company’s website at www.novavax.com under “Latest Investor Presentation.”\n\n \n\n**Cautionary Note Regarding Forward-Looking\nStatements**. The Investor Presentation contains forward-looking statements that involve certain risks and uncertainties that could\ncause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary notes in\nthe Investor Presentation regarding these forward-looking statements.\n\n \n\nThe information in Item 2.02 and Item 7.01, including\nExhibit 99.1, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities\nExchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by\nreference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Securities\nExchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing. In addition, the contents\nof the Company’s website are not incorporated by reference into this Current Report on Form 8-K and you should not consider\ninformation provided on the Company’s website to be part of this Current Report on Form 8-K."}